Scrub-Stat

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use as a surgical hand scrub, significantly reducing the number of microorganisms on the hands and forearms prior to surgical procedures or patient care. Additionally, it serves as a handwash for healthcare personnel, aiding in the reduction of bacteria that may potentially cause disease.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Surgical hand scrubbing requires the removal of all jewelry prior to the procedure. Healthcare professionals should begin by wetting their hands and forearms with water. Following this, they should dispense 9 pumps (5 grams) of the product into their hands. A thorough wash or scrub of the hands and forearms should be performed for a duration of 3 minutes, with particular attention given to the nails, cuticles, and interdigital spaces. After this initial scrubbing, hands and forearms must be rinsed thoroughly under running water.

For a second application, the process should be repeated by dispensing another 9 pumps (5 grams) of the product into the hands. A further wash for an additional 3 minutes is required, followed by another thorough rinse under running water. Finally, hands and forearms should be dried thoroughly.

For healthcare personnel handwashing, the procedure begins with wetting the hands with water. Subsequently, 9 pumps (5 grams) of the product should be dispensed into the hands. A vigorous wash should be conducted for 30 seconds, ensuring all areas are adequately cleaned. After washing, hands must be rinsed thoroughly and dried completely.

Contraindications

Use of this product is contraindicated in individuals with a known allergy to chlorhexidine gluconate or any other component of the formulation. Additionally, it should not be used in patients with wounds that extend beyond the superficial layers of the skin due to the potential for adverse effects.

Contact with the eyes, ears, or mouth must be avoided, as exposure may result in serious and permanent eye injury or deafness if introduced into the middle ear through perforated eardrums. In the event of contact, immediate rinsing with cold water is recommended.

Discontinue use and consult a healthcare professional if irritation, sensitization, or an allergic reaction occurs, as these may indicate a serious condition.

Warnings and Precautions

This product is intended for external use only.

Allergy Alert: The formulation may induce a severe allergic reaction in susceptible individuals. Symptoms indicative of such a reaction may include wheezing or difficulty breathing, shock, facial swelling, hives, and rash. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance.

Users should refrain from using this product if they have a known allergy to chlorhexidine gluconate or any other component of the formulation.

When utilizing this product, it is crucial to avoid contact with the eyes, ears, and mouth. Exposure to the eyes may result in serious and permanent injury, while instillation into the middle ear through perforated eardrums may lead to deafness. Should contact with these areas occur, it is essential to rinse thoroughly with cold water without delay.

Routine use of this product is not recommended for individuals with wounds that extend beyond the superficial layers of the skin.

Discontinuation of Use: Users should stop using the product and consult a healthcare professional if any signs of irritation, sensitization, or allergic reaction manifest, as these may indicate a serious underlying condition.

This product should be stored out of reach of children. In the event of accidental ingestion, immediate medical attention should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients using this product may experience a range of adverse reactions, some of which can be serious. A notable concern is the potential for severe allergic reactions, which may manifest as wheezing or difficulty breathing, shock, facial swelling, hives, or rash. In the event of an allergic reaction, it is imperative that patients discontinue use immediately and seek medical assistance.

The product should not be used by individuals with a known allergy to chlorhexidine gluconate or any other ingredient contained within. Caution is advised during use, as the product must be kept out of the eyes, ears, and mouth. Contact with these areas may lead to serious and permanent eye injury or deafness if instilled in the middle ear through perforated eardrums. Should contact occur, patients are advised to rinse the affected area with cold water promptly.

Patients should also refrain from routine use of this product on wounds that extend beyond the superficial layers of the skin. If irritation, sensitization, or any signs of an allergic reaction occur, patients should stop using the product and consult a healthcare professional, as these symptoms may indicate a serious condition.

In cases where the product is ingested, immediate medical help should be sought, or the Poison Control Center should be contacted without delay.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Scrub-Stat (chlorhexidine gluconate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients, particularly premature infants and those under 2 months of age, should be treated with caution. The use of these products in this population may lead to irritation or chemical burns. It is essential for healthcare professionals to closely monitor these patients to mitigate potential risks associated with their use.

Geriatric Use

Elderly patients may not have specific information regarding the use of SCRUB-STAT chlorhexidine gluconate solution, as the drug insert does not provide details on dosage adjustments, safety concerns, or special precautions for this population.

Healthcare providers should exercise caution when administering this solution to geriatric patients, considering the absence of targeted clinical findings or recommendations. Monitoring for any adverse effects or unusual responses in elderly patients is advisable, given their potential for altered pharmacokinetics and increased sensitivity to medications.

Pregnancy

There is no specific information available regarding the use of SCRUB-STAT chlorhexidine gluconate solution during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should weigh the potential benefits against any unknown risks when considering the use of this product in women of childbearing potential. Further studies may be necessary to fully understand the implications of chlorhexidine gluconate exposure during pregnancy.

Lactation

Lactating mothers should use this product with caution, particularly in the case of premature infants or those under 2 months of age. There is a risk that the product may cause irritation or chemical burns in breastfed infants. Therefore, careful consideration and monitoring are advised when administering this product to lactating mothers who are nursing young infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, it is imperative to keep the product out of reach of children. Should ingestion occur, immediate medical assistance is required. Healthcare professionals should advise caregivers to contact a Poison Control Center without delay.

Prompt intervention is crucial to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage any clinical manifestations that arise.

Management procedures may include supportive care and symptomatic treatment as necessary. Continuous monitoring of the patient’s condition is recommended to ensure appropriate responses to any complications that may develop.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients to avoid contact with the eyes, ears, and mouth, as exposure may lead to serious and permanent eye injury or potential deafness if instilled in the middle ear through perforated eardrums. In the event of contact with these areas, patients should rinse with cold water immediately.

Healthcare providers should also caution patients against routine use of the medication if they have wounds that extend beyond the superficial layers of the skin. Patients should be advised to discontinue use and consult a doctor if they experience any irritation, sensitization, or allergic reactions, as these symptoms may indicate a serious condition.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 20-25°C (68-77°F) to maintain its efficacy. Care should be taken to avoid exposure to excessive heat, defined as temperatures above 104°F (40°C), as well as to prevent freezing. Proper storage conditions are crucial to ensure the integrity and stability of the product throughout its shelf life.

Additional Clinical Information

The route of administration for the product is topical. Clinicians should advise patients to contact emergency medical services for urgent inquiries: in the USA and Canada, they can call 1.800.328.0026, while those outside these regions can reach out to 1.651.222.5352 for assistance. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Scrub-Stat, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)